Sign in

CIK 0001370053

  • Non-accelerated filer
  • Smaller reporting company

ANAPTYSBIO, INC

Sign in to watch
Ticker
ANAB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
203828755
Phone
+1 858-362-6295
Business address
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
Former names
ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market sale President, CEO sold 17,679 shares at an average $61.61 ($1,089,199)
  3. 4 Planned sale CHIEF LEGAL OFFICER sold 10,000 shares at $54.00 ($540,000)
  4. 4 Open-market sale Director sold 11,000 shares at an average $48.23 ($530,531)
  5. 4 Open-market sale Chief Medical Officer sold 3,650 shares at $44.71 ($163,192)
  6. 4 Open-market sale CHIEF FINANCIAL OFFICER sold 2,515 shares at $44.71 ($112,446)
  7. 4 Open-market sale CHIEF LEGAL OFFICER sold 2,210 shares at $44.71 ($98,809)
  8. 4 Open-market sale President, CEO sold 14,281 shares at $44.71 ($638,504)
  9. 4 Open-market sale CHIEF LEGAL OFFICER sold 9,639 shares at an average $45.56 ($439,200)
  10. 4 Open-market sale Chief Medical Officer sold 2,235 shares at $45.11 ($100,821)
  11. 4 Open-market sale President, CEO sold 9,202 shares at $45.11 ($415,102)
  12. 4 Open-market sale CHIEF FINANCIAL OFFICER sold 1,908 shares at $45.11 ($86,070)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market sale President, CEO sold 15,309 shares at $43.26 ($662,267)

Page 2 of 15 · 297 filings